This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Cytomegalovirus Treatment Market

Market Insights on Cytomegalovirus Treatment covering sales outlook, demand forecast & up-to-date key trends

Cytomegalovirus Treatment Market By Drug Type (Valganciclovir, Ganciclovir, Cidofovir, Foscarnet), Application (Stem Cell Transplantation, Organ Transplantation, Congenital CMV Infection), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, e-Commerce) & Region - Forecast to 2022 - 2028

Cytomegalovirus Treatment Market Outlook (2022-2028)

[221 Pages Report] Revenue from the global cytomegalovirus treatment market currently stands at US$ 228.8 Mn in 2022. Rising at a CAGR of 6.1% (2022-2028), demand for cytomegalovirus treatment is predicted to reach a market valuation of US$ 326 Mn by the end of 2028.

Global Cytomegalovirus Treatment Market Size (2022)

US$ 228.8 Mn

Net Revenue Estimation (2028)

US$ 326 Mn

Global Growth Rate (2022-2028)

6.1% CAGR

Market Share of Hospital Pharmacies

47.8%

Cytomegalovirus treatment contributes 0.8% to the global infectious disease diagnostics market revenue. Increasing instances of viral infections and rising awareness of cytomegalovirus symptoms are expected to propel demand for cytomegalovirus treatment on a global level.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

6.10%

H1, 2022 Projected

6.08%

H1, 2022 Outlook

5.48%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 60 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 62 ↓

The comparative analysis and market growth rate of global cytomegalovirus treatment market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 60 BPS. A decline in BPS growth is expected in H1-2022 over H1- 2021 duration with 62 Basis Point Share (BPS).

The market for cytomegalovirus treatment is subject to changes as per the macro and industrial standards in relevance to stringent regulations in biopharmaceuticals development and production and licensing.

The market observes a decline in the BPS values owed to the inefficacy of the therapy in patients with severe immunosuppression or disseminated disease. With the rising cases of such incidences after the global coronavirus pandemic, the limitations for cytomegalovirus treatment posed a negative impact upon the market growth, thus resulting in the dropped BPS values.

Conversely, with the recent FDA approval of the first drug for adults and paediatric patients with cytomegalovirus infections and diseases which cannot be managed with the current available antiviral treatment methods in 2022, has paved way for the market to observe a positive outlook towards growth over the forecasted years.

The key development in the market includes the adoption of oral antivirals such as ganciclovir for the management of cytomegalovirus in immunocompromised patients.

Demand Survey Of Cytomegalovirus Treatment (2013 To 2021) Vs Market Statistics (2022 To 2028)

The world has seen substantial rise in viral infections and other infectious diseases, and this has propelled demand for better diagnostic and treatment solutions. The cytomegalovirus treatment market exhibited expansion at a CAGR of 5.7% from 2013 to 2021.

Increasing prevalence of congenital CMV infections, rising awareness about cytomegalovirus symptoms, increasing spending on research & development activities, rising clinical trials and studies for CMV infections, etc., are major trends that will guide cytomegalovirus treatment demand through 2028.

The risk of reactivation of cytomegalovirus infections in multiple individuals has been observed and this is one of the areas of prime focus for many cytomegalovirus treatment providers. The use of antiviral agents that have very low risks associated with them is seeing high demand in the development of antiviral drugs for cytomegalovirus diseases. Antiviral agents such as ganciclovir and valganciclovir are expected to see a rise in popularity over the forecast period.

Cytomegalovirus Treatment Market Download Report Brochure

Risks and side effects associated with antiviral drugs for cytomegalovirus diseases are anticipated to restrain market potential to a certain extent over the forecast period. The cytomegalovirus treatment industry is projected to rise at a steady CAGR of 6.1% from 2022 to 2028.

What Can Positively Influence Demand For Cytomegalovirus Treatment?

“Increasing Focus on Development of CMV Vaccines”

Awareness of cytomegalovirus symptoms is being raised across the world by multiple initiatives taken by governments and non-profit organizations to bolster public safety. Clinical trials are being carried out to boost the development of novel cytomegalovirus treatment.

  • For instance, in December 2021, AIDS Clinical Trials Group (ACTG) announced the launch of new clinical trials to study the effects of new CMV vaccines in adults. This trial will explore the effect of immune response from the vaccine in people living with HIV infections and its effectiveness in suppressing CMV replication.

How Is Cytomegalovirus Treatment Market Potential Being Hindered?

“Risks of Antiviral Drugs for Cytomegalovirus Diseases Could Adversely Impact Market Growth”

Very little is known about CMV infections, and this has proven to be a major obstacle to cytomegalovirus diagnosis and cytomegalovirus testing. Increasing demand for cytomegalovirus natural treatment is also expected to constrain the adoption of antiviral drugs for cytomegalovirus diseases.

These factors are expected to have a hindering effect on global cytomegalovirus treatment device demand through 2028.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How Will The Global Cytomegalovirus Treatment Market Fare Across Regions?

“High R&D Activity in North America to Boost Cytomegalovirus Diagnosis”

Detailed assessment of market stance across regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA) has been profiled in this revised FMI market analysis.

Demand for cytomegalovirus treatment products in North America is anticipated to hold a major market share in the global marketplace over the forecast. The presence of major cytomegalovirus treatment providers and rapid advancements in cytomegalovirus diagnosis and cytomegalovirus treatment are expected to shape market potential.

Rising prevalence of congenital CMV infections, increasing use of combinational antiviral therapies, and increasing awareness of cytomegalovirus treatment in stem cell transplants are expected to be major trends in the Europe cytomegalovirus treatment market over the forecast period.

Increasing investments in research & development activities, rising healthcare expenditure, and increasing popularity of cytomegalovirus natural treatment are major factors that influence cytomegalovirus treatment demand in South Asia and East Asia. Rising focus on boosting cytomegalovirus testing in these regions is expected to majorly favour market potential.

Country-Wise Analysis

Will India Be a Lucrative Market for Cytomegalovirus Treatment Product Manufacturers?

“Increasing Focus on Healthcare & Rising Awareness about Cytomegalovirus Symptoms in India”

The healthcare infrastructure in India is rapidly changing and the focus on health and hygiene has fostered a new wave of demand for better diagnostic and treatment solutions in the nation. Government initiatives are boosting awareness about viral infections and are further bolstering awareness about cytomegalovirus symptoms in India.

High population, increasing prevalence of HIV infections, high birthrate, etc., are some of the major factors that influence cytomegalovirus treatment market potential in India. Cytomegalovirus diagnosis and cytomegalovirus testing are expected to increase in India as awareness about cytomegalovirus symptoms increases through 2028.

What is the Demand Outlook for Cytomegalovirus Treatment in the U.S.?

“High Research Activity to Explore Cytomegalovirus Pathology to Boost Market Potential”

The U.S. is known for its well-established healthcare infrastructure, and this has made it a highly lucrative market for the healthcare industry. Cytomegalovirus treatment providers are expected to further advance their research & development activities to provide better cytomegalovirus diagnosis and treatment.

Rising research for cytomegalovirus testing, increasing investments from government and non-profit research organizations, and rising availability of cytomegalovirus diagnosis procedures are expected to be major factors influencing cytomegalovirus treatment market potential through 2028.

  • For instance, in November 2021, the U.S. FDA (Food and Drug Administration) approved the first-of-its-kind treatment for post-transplant cytomegalovirus (CMV) infections. Livtencity (maribavir) is designed for the treatment of pediatric patients (12 years or older with a minimum weight of 35 kilograms) and adults.
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-Wise Analysis

Which Distribution Channel Accounts for Higher Demand for Cytomegalovirus Treatment Products?

“Hospital Pharmacies to Hold Dominant Market Share”

In 2022, hospital pharmacies account for 46.8% of the global cytomegalovirus treatment industry landscape. With most cytomegalovirus diagnosis procedures being accessible only through professional subscriptions, this has boosted their sales via hospital pharmacies, which are more accessible to patients and are recommended by professionals.

Other distribution channels such as retail pharmacies and e-Commerce currently hold market shares of 36.7% and 16.4%, respectively, in 2022, in the global cytomegalovirus treatment space.

COVID-19 Impact Survey

In 2020, the healthcare industry was revolutionized by the emergence of coronavirus infections and adversely affected multiple treatment and diagnostic procedures across the world. As lockdown restrictions were imposed and outdoor activity was largely restricted, this led to a substantial drop in the research and development activities related to cytomegalovirus treatment.

Demand for cytomegalovirus treatment also experienced a drop during the pandemic era as all healthcare resources and professionals were focused on the treatment of coronavirus infections. However, the cytomegalovirus treatment market is predicted to make a steady comeback in the post-pandemic era as infections subside and the world returns to a new normal.

Competitive Landscape

Cytomegalovirus treatment providers are investing in the research & development of innovative and more effective treatments for CMV infections.

  • In November 2021, Modernam a renowned name in the pharmaceutical industry, announced the initiation of a Phase III trial of its cytomegalovirus vaccine. The trial is dubbed 'CMVictory', and is expected to have a revolutionary impact on worldwide CMV diagnosis and treatment.

Cytomegalovirus Treatment Industry Report Scope

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2013-2021

Market Analysis

US$ Mn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Turkey
  • South Africa
  • and GCC Countries

Key Market Segments Covered

  • Drug Type
  • Application
  • Distribution Channel
  • Region

Key Companies Profiled

Pricing

Available upon Request

Key Segments Of Cytomegalovirus Treatment Industry Survey

Cytomegalovirus Treatment Market by Drug Type:

  • Valganciclovir for Cytomegalovirus Treatment
  • Ganciclovir for Cytomegalovirus Treatment
  • Cidofovir for Cytomegalovirus Treatment
  • Foscarnet for Cytomegalovirus Treatment
  • Others

Cytomegalovirus Treatment Market by Application:

  • Stem Cell Transplantations
  • Organ Transplantations
  • Congenital CMV Infections
  • Others

Cytomegalovirus Treatment Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • e-Commerce

Cytomegalovirus Treatment Market by Region:

  • North America Cytomegalovirus Treatment Market
  • Latin America Cytomegalovirus Treatment Market
  • Europe Cytomegalovirus Treatment Market
  • East Asia Cytomegalovirus Treatment Market
  • South Asia & Pacific Cytomegalovirus Treatment Market
  • Middle East & Africa (MEA) Cytomegalovirus Treatment Market

Frequently Asked Questions

Demand for cytomegalovirus treatment is predicted to increase at a CAGR of 6.1% from 2022 to 2028.

The global cytomegalovirus treatment market stands at a net worth US$ 228.8 Mn in 2022.

By 2028, the global cytomegalovirus treatment market is anticipated to attain a valuation of US$ 326 Mn.

Prime market players such as Chimerix Inc., Thermo Fisher Scientific, Abbot, Becton Dickinson and Company, Pfizer Inc., Merck & Company Inc., Mylan N.V., Johnson & Johnson, and Bio-Rad Laboratories Inc. have been profiled in this market survey.

At present, hospital pharmacies account for a dominant share of 46.8% in the global cytomegalovirus treatment industry.

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition

3. Market Background

    3.1. Market Overview

    3.2. Macroeconomic Assumptions

    3.3. Global Economic Outlook

4. Market Dynamics

    4.1. Market Dynamics

        4.1.1. Drivers

        4.1.2. Restraints

        4.1.3. Opportunity Analysis

        4.1.4. Trends

5. Cytomegalovirus Treatment Market: Key Inclusions 

    5.1. Pipeline Analysis 

    5.2. Reimbursement Scenarios

    5.3. Cytomegalovirus Treatment: Timeline  

6. North America Cytomegalovirus Treatment Market Analysis 2013–2021 and Opportunity Assessment 2022–2028

    6.1. Introduction

    6.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021

        6.2.1. U.S.

        6.2.2. Canada

    6.3. Market Size (US$ Mn) Opportunity Assessment By Country, 2022–2028

    6.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021

        6.4.1. Ganciclovir

        6.4.2. Valganciclovir

        6.4.3. Foscarnet

        6.4.4. Cidofovir

        6.4.5. Others 

    6.5. Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2022–2028

    6.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2021

        6.6.1. Stem Cell Transplantation

        6.6.2. Organ Transplantation

        6.6.3. Congenital CMV infection

        6.6.4. Others 

    6.7. Market Size (US$ Mn) Opportunity Assessment By Application, 2022–2028

    6.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        6.8.1. Hospital pharmacies

        6.8.2. Retail Pharmacies

        6.8.3. E-commerce

    6.9.  Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2022–2028

    6.10. Market Attractiveness Analysis

        6.10.1. By Country

        6.10.2. By Drug Type

        6.10.3. By Application

        6.10.4. By Distribution Channel

    6.11. Drivers and Restraints – Impact Analysis

7. Western Europe Cytomegalovirus Treatment Market Analysis 2013–2021 and Opportunity Assessment 2022–2028

    7.1. Introduction

    7.2. Historical Market Size (US$ Mn) By Country, 2013–2021

        7.2.1. Germany

        7.2.2. France

        7.2.3. U.K.

        7.2.4. Spain

        7.2.5. Italy

        7.2.6. Rest of Western Europe

    7.3. Market Size (US$ Mn) Opportunity Assessment By Country, 2022–2028

    7.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021

        7.4.1. Ganciclovir

        7.4.2. Valganciclovir

        7.4.3. Foscarnet

        7.4.4. Cidofovir

        7.4.5. Others 

    7.5. Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2022–2028

    7.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2021

        7.6.1. Stem Cell Transplantation

        7.6.2. Organ Transplantation

        7.6.3. Congenital CMV infection

        7.6.4. Others 

    7.7. Market Size (US$ Mn) Opportunity Assessment By Application, 2022–2028

    7.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        7.8.1. Hospital pharmacies

        7.8.2. Retail Pharmacies

        7.8.3. E-commerce

    7.9.  Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2022–2028

    7.10. Market Attractiveness Analysis

        7.10.1. By Country

        7.10.2. By Drug Type

        7.10.3. By Application

        7.10.4. By Distribution Channel

    7.11. Drivers and Restraints – Impact Analysis

8. Eastern Europe Cytomegalovirus Treatment Market Analysis 2013–2021 and Opportunity Assessment 2022–2028

    8.1. Introduction

    8.2. Historical Market Size (US$ Mn) By Country, 2013–2021

        8.2.1. Russia

        8.2.2. Poland

        8.2.3. Rest of Eastern Europe

    8.3. Market Size (US$ Mn) Opportunity Assessment By Country, 2022–2028

    8.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021

        8.4.1. Ganciclovir

        8.4.2. Valganciclovir

        8.4.3. Foscarnet

        8.4.4. Cidofovir

        8.4.5. Others 

    8.5. Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2022–2028

    8.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2021

        8.6.1. Stem Cell Transplantation

        8.6.2. Organ Transplantation

        8.6.3. Congenital CMV infection

        8.6.4. Others 

    8.7. Market Size (US$ Mn) Opportunity Assessment By Application, 2022–2028

    8.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        8.8.1. Hospital pharmacies

        8.8.2. Retail Pharmacies

        8.8.3. E-commerce

    8.9.  Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2022–2028

    8.10. Market Attractiveness Analysis

        8.10.1. By Country

        8.10.2. By Drug Type

        8.10.3. By Application

        8.10.4. By Distribution Channel

    8.11. Drivers and Restraints – Impact Analysis

9. Latin America Cytomegalovirus Treatment Market Analysis 2013–2021 and Opportunity Assessment 2022–2028

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) By Country, 2013–2021

        9.2.1. Brazil

        9.2.2. Mexico

        9.2.3. Rest of Latin America

    9.3. Market Size (US$ Mn) Opportunity Assessment By Country, 2022–2028

    9.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021

        9.4.1. Ganciclovir

        9.4.2. Valganciclovir

        9.4.3. Foscarnet

        9.4.4. Cidofovir

        9.4.5. Others 

    9.5. Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2022–2028

    9.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2021

        9.6.1. Stem Cell Transplantation

        9.6.2. Organ Transplantation

        9.6.3. Congenital CMV infection

        9.6.4. Others 

    9.7. Market Size (US$ Mn) Opportunity Assessment By Application, 2022–2028

    9.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        9.8.1. Hospital pharmacies

        9.8.2. Retail Pharmacies

        9.8.3. E-commerce

    9.9.  Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2022–2028

    9.10. Market Attractiveness Analysis

        9.10.1. By Country

        9.10.2. By Drug Type

        9.10.3. By Application

        9.10.4. By Distribution Channel

    9.11. Drivers and Restraints – Impact Analysis

10. Asia Pacific excluding China (APEC) Cytomegalovirus Treatment Market   Analysis 2013–2021 and Opportunity Assessment 2022–2028

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) By Country, 2013–2021

        10.2.1. India

        10.2.2. Australia and New Zealand

        10.2.3. Japan

        10.2.4. Rest of APEJ

    10.3. Market Size (US$ Mn) Opportunity Assessment By Country, 2022–2028

    10.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021

        10.4.1. Ganciclovir

        10.4.2. Valganciclovir

        10.4.3. Foscarnet

        10.4.4. Cidofovir

        10.4.5. Others 

    10.5. Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2022–2028

    10.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2021

        10.6.1. Stem Cell Transplantation

        10.6.2. Organ Transplantation

        10.6.3. Congenital CMV infection

        10.6.4. Others 

    10.7. Market Size (US$ Mn) Opportunity Assessment By Application, 2022–2028

    10.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        10.8.1. Hospital pharmacies

        10.8.2. Retail Pharmacies

        10.8.3. E-commerce

    10.9.  Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2022–2028

    10.10. Market Attractiveness Analysis

        10.10.1. By Country

        10.10.2. By Drug Type

        10.10.3. By Application

        10.10.4. By Distribution Channel

    10.11. Drivers and Restraints – Impact Analysis

11. China Cytomegalovirus Treatment Market  Analysis 2013–2021 and Opportunity Assessment 2022–2028

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021

        11.2.1. Ganciclovir

        11.2.2. Valganciclovir

        11.2.3. Foscarnet

        11.2.4. Cidofovir

        11.2.5. Others 

    11.3. Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2022–2028

    11.4. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2021

        11.4.1. Stem Cell Transplantation

        11.4.2. Organ Transplantation

        11.4.3. Congenital CMV infection

        11.4.4. Others 

    11.5. Market Size (US$ Mn) Opportunity Assessment By Application, 2022–2028

    11.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        11.6.1. Hospital pharmacies

        11.6.2. Retail Pharmacies

        11.6.3. E-commerce

    11.7.  Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2022–2028

    11.8. Market Attractiveness Analysis

        11.8.1. By Drug Type

        11.8.2. By Application

        11.8.3. By Distribution Channel

    11.9. Drivers and Restraints – Impact Analysis

12. MEA Cytomegalovirus Treatment Market   Analysis 2013–2021 and Opportunity Assessment 2022–2028

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) By Country, 2013–2021

        12.2.1. GCC Countries

        12.2.2. South Africa

        12.2.3. Rest of MEA

    12.3. Market Size (US$ Mn) Opportunity Assessment By Country, 2022–2028

    12.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021

        12.4.1. Ganciclovir

        12.4.2. Valganciclovir

        12.4.3. Foscarnet

        12.4.4. Cidofovir

        12.4.5. Others 

    12.5. Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2022–2028

    12.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2021

        12.6.1. Stem Cell Transplantation

        12.6.2. Organ Transplantation

        12.6.3. Congenital CMV infection

        12.6.4. Others 

    12.7. Market Size (US$ Mn) Opportunity Assessment By Application, 2022–2028

    12.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        12.8.1. Hospital pharmacies

        12.8.2. Retail Pharmacies

        12.8.3. E-commerce

    12.9.  Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2022–2028

    12.10. Market Attractiveness Analysis

        12.10.1. By Country

        12.10.2. By Drug Type

        12.10.3. By Application

        12.10.4. By Distribution Channel

    12.11. Drivers and Restraints – Impact Analysis

13. Forecast Factors: Relevance and Impact

14. Competition Analysis

    14.1. Competition Dashboard

    14.2. Company Deep Dive

        14.2.1. Merck & Co. Inc.,

            14.2.1.1. Overview

            14.2.1.2. Product and Application Portfolio

            14.2.1.3. Analyst Commentary 

            14.2.1.4. Strategy

                14.2.1.4.1. Marketing Strategy

                14.2.1.4.2. Product Strategy

                14.2.1.4.3. Channel Strategy

        14.2.2. Mylan N.V.

        14.2.3. Chimerix, Inc., 

        14.2.4. Thermo Fisher Scientific

        14.2.5. Abbott

        14.2.6. Becton, Dickinson and Company, 

        14.2.7. Johnson & Johnson, 

        14.2.8. Bio-Rad Laboratories, Inc.,

        14.2.9. F. Hoffmann-La Roche Ltd

        14.2.10. Pfizer 

15. Global Cytomegalovirus Treatment Market  Analysis 2013–2021 and Opportunity Assessment 2022–2028, By Region

    15.1. Introduction / Key Findings

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2021 

        15.2.1. North America

        15.2.2. Western Europe

        15.2.3. Eastern Europe

        15.2.4. Latin America

        15.2.5. Asia Pacific excluding China

        15.2.6. China

        15.2.7. Middle East and Africa

    15.3. Market Size (US$ Mn) Opportunity Assessment By Region, 2022–2028

    15.4. Market Attractiveness Analysis By Region

16. Global Cytomegalovirus Treatment Market  Analysis 2013–2021 and Opportunity Assessment 2022–2028, By Drug Type

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Trend Analysis By Drug Type, 2013–2021

        16.2.1. Ganciclovir

        16.2.2. Valganciclovir

        16.2.3. Foscarnet

        16.2.4. Cidofovir

        16.2.5. Others 

    16.3.  Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2022–2028

    16.4. Market Attractiveness Analysis By Drug Type

17. Global Cytomegalovirus Treatment Market Analysis 2013–2021 and Opportunity Assessment 2022–2028, By Application

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2021

        17.2.1. Stem Cell Transplantation

        17.2.2. Organ Transplantation

        17.2.3. Congenital CMV infection

        17.2.4. Others

    17.3.  Market Size (US$ Mn) Opportunity Assessment By Application, 2022–2028

    17.4. Market Attractiveness Analysis By Application

18. Global Cytomegalovirus Treatment Market Analysis 2013–2021 and Opportunity Assessment 2022–2028, By Distribution Channel 

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        18.2.1. Hospital pharmacies

        18.2.2. Retail Pharmacies

        18.2.3. E-commerce

    18.3.  Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2022–2028

    18.4. Market Attractiveness Analysis By Distribution Channel

19. Global Cytomegalovirus Treatment Market Analysis 2013–2021 and Opportunity Assessment 2022–2028

    19.1. Market Value Share Analysis 

        19.1.1. By Country

        19.1.2. By Drug Type

        19.1.3. By Application

        19.1.4. By Distribution Channel

    19.2. Y-o-Y Growth Analysis

        19.2.1. By Country

        19.2.2. By Drug Type

        19.2.3. By Application

        19.2.4. By Distribution Channel

    19.3. Absolute $ Opportunity

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Expenditure on Health, (% of GDP), by Country, 2013 - 2021

Table 02: Expenditure on Health, (% of GDP), by Country, 2013 - 2021

Table 03: Respective codes for Cytomegalovirus Treatment 

Table 04: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Country

Table 05: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Drug Type

Table 06: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Application

Table 07: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Distribution Channel

Table 08: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Country

Table 09: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Drug Type

Table 10: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Application

Table 11: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Distribution Channel

Table 12: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Country

Table 13: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Drug Type

Table 14: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Application

Table 15: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Distribution Channel

Table 16: Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Country

Table 17: Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Drug Type

Table 18: Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Application

Table 19: Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Distribution Channel

Table 20: APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Country

Table 21: APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Drug Type

Table 22: APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Application

Table 23: APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Distribution Channel

Table 24: China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Drug Type

Table 25: China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Application

Table 26: China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Distribution Channel

Table 27: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Country

Table 28: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Drug Type

Table 29: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Application

Table 30: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Distribution Channel

Table 31: Global Cytomegalovirus Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2022–2028, By Region 

Table 32: Global Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Drug Type

Table 33: Global Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Application

Table 34: Global Cytomegalovirus Treatment Market Value (US$ Mn) Analysis 2013-2021 and Opportunity Assessment 2022-2028, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Cytomegalovirus Treatment Market Split By Drug Type (2022)

Figure 02: Global Cytomegalovirus Treatment Market Split By Application (2022)

Figure 03: Global Cytomegalovirus Treatment Market Value 2022 & 2028

Figure 04: Global Cytomegalovirus Treatment Market Split By Distribution Channel (2022)

Figure 05: Global Cytomegalovirus Treatment Market Split By Region (2022)

Figure 06: Global Overview of Clinical Trails, by Region 

Figure 07: Clinical trials of cytomegalovirus treatments as reported, by Phase

Figure 08: Reported number of study type for each clinical trial 

Figure 9: North America Cytomegalovirus Treatment Market Value Share, By Drug Type (2022)

Figure 10: North America Cytomegalovirus Treatment Market Value Share, By Application (2022)

Figure 11: North America Cytomegalovirus treatment market value analysis US$ 

Figure 12: North America Cytomegalovirus Treatment Market Value Share, By Distribution Channel (2022) 

Figure 13: North America Cytomegalovirus Treatment Market Value Share, By Country (2022)

Figure 14: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 15 : North America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 16: U.S. Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 17 : U.S. Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 18: Canada Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 19 : Canada Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 20 : North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Ganciclovir

Figure 21: North America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Ganciclovir

Figure 22: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Valganciclovir

Figure 23: North America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Valganciclovir

Figure 24: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Foscarnet

Figure 25: North America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Foscarnet

Figure 26: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Cidofovir

Figure 27: North America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Cidofovir

Figure 28: North America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Others

Figure 29: North America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Others

Figure 30: North America Cytomegalovirus Treatment Market Attractiveness Analysis, By Drug Type 

Figure 31: North America Cytomegalovirus Treatment Market Attractiveness Analysis, By Application

Figure 32: North America Cytomegalovirus Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 33: North America Cytomegalovirus Treatment Market Attractiveness Analysis, By Country

Figure 34: Latin America Cytomegalovirus Treatment Market Value Share, By Drug Type (2022)

Figure 35: Latin America Cytomegalovirus Treatment Market Value Share, By Application (2022)

Figure 36: Latin America Cytomegalovirus treatment market value analysis US$ 

Figure 37: Latin America Cytomegalovirus Treatment Market Value Share, By Distribution Channel (2022) 

Figure 38: Latin America Cytomegalovirus Treatment Market Value Share, By Country (2022)

Figure 39: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 40 : Latin America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 41: Brazil Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 42 : Brazil Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 43: Mexico Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 44 : Mexico Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 45 : Rest Of Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 46: Rest Of Latin America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 47 : Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Ganciclovir

Figure 48 : Latin America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Ganciclovir

Figure 49 : Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Valganciclovir

Figure 50 : Latin America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Valganciclovir

Figure 51 : Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Foscarnet

Figure 52: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Foscarnet

Figure 53: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Cidofovir

Figure 54: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Cidofovir

Figure 55: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Others

Figure 56: Latin America Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Others

Figure 57: Latin America Cytomegalovirus Treatment Market Attractiveness Analysis, By Drug Type 

Figure 58: Latin America Cytomegalovirus Treatment Market Attractiveness Analysis, By Application

Figure 59: Latin America Cytomegalovirus Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 60: Latin America Cytomegalovirus Treatment Market Attractiveness Analysis, By Country

Figure 61: Western Europe Cytomegalovirus Treatment Market Value Share, By Drug Type (2022)

Figure 62: Western Europe Cytomegalovirus Treatment Market Value Share, By Application (2022)

Figure 63: Western Europe Cytomegalovirus treatment market value analysis US$ 

Figure 64: Western Europe Cytomegalovirus Treatment Market Value Share, By Distribution Channel (2022) 

Figure 65: Western Europe Cytomegalovirus Treatment Market Value Share, By Country (2022)

Figure 66: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 67 : Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 68: U.K. Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 69 : U.K. Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 70 : Germany Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 71: Germany Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 72: France Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 73 : France Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 74 : Italy Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 75 : Italy Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 76: Spain Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 77: Spain Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 78: Rest of Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 79: Rest of Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 80 : Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Ganciclovir

Figure 81: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Ganciclovir

Figure 82: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Valganciclovir

Figure 83: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Valganciclovir

Figure 84: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Foscarnet

Figure 85: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Foscarnet

Figure 86: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Cidofovir

Figure 87: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Cidofovir

Figure 88: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Others

Figure 89: Western Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Others

Figure 90: Western Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Drug Type 

Figure 91: Western Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Application

Figure 92: Western Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 93: Western Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Country

Figure 94: Eastern Europe Cytomegalovirus Treatment Market Value Share, By Drug Type (2022)

Figure 95: Eastern Europe Cytomegalovirus Treatment Market Value Share, By Application (2022)

Figure 96: Eastern Europe Cytomegalovirus treatment market value analysis US$ 

Figure 97: Eastern Europe Cytomegalovirus Treatment Market Value Share, By Distribution Channel (2022) 

Figure 98: Eastern Europe Cytomegalovirus Treatment Market Value Share, By Country (2022)

Figure 99: Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 100: Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 101: Russia Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 102 : Russia Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 103 : Poland Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 104 : Poland Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 105 : Rest of Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 106: Rest of Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 107 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Ganciclovir

Figure 108 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Ganciclovir

Figure 109 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Valganciclovir

Figure 110 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Valganciclovir

Figure 111 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Foscarnet

Figure 112 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Foscarnet

Figure 113 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Cidofovir

Figure 114 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Cidofovir

Figure 115 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Others

Figure 116 : Eastern Europe Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Others

Figure 117: Eastern Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Drug Type 

Figure 118: Eastern Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Application

Figure 119: Eastern Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 120: Eastern Europe Cytomegalovirus Treatment Market Attractiveness Analysis, By Country

Figure 121: APEC Cytomegalovirus Treatment Market Value Share, By Drug Type (2022)

Figure 122: APEC Cytomegalovirus Treatment Market Value Share, By Application (2022)

Figure 123: APEC Cytomegalovirus treatment market value analysis US$ 

Figure 124: APEC Cytomegalovirus Treatment Market Value Share, By Distribution Channel (2022) 

Figure 125: APEC Cytomegalovirus Treatment Market Value Share, By Country (2022)

Figure 126: APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 127 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 128: India Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 129: India Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 130 : Australia & NZ Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 131 : Australia & NZ Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 132: Japan Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 133 : Japan Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 134 : Rest of APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 135 : Rest of APEC Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 136 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Ganciclovir

Figure 137 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Ganciclovir

Figure 138 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Valganciclovir

Figure 139 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Valganciclovir

Figure 140 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Foscarnet

Figure 141 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Foscarnet

Figure 142 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Cidofovir

Figure 143 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Cidofovir

Figure 144 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Others

Figure 145 : APEC Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Others

Figure 146: APEC Cytomegalovirus Treatment Market Attractiveness Analysis, By Drug Type 

Figure 147: APEC Cytomegalovirus Treatment Market Attractiveness Analysis, By Application

Figure 148: APEC Cytomegalovirus Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 149: APEC Cytomegalovirus Treatment Market Attractiveness Analysis, By Country

Figure 150: China Cytomegalovirus Treatment Market Value Share, By Drug Type (2022)

Figure 151: China Cytomegalovirus Treatment Market Value Share, By Application (2022)

Figure 152: China Cytomegalovirus treatment market value analysis US$ 

Figure 153: China Cytomegalovirus Treatment Market Value Share, By Distribution Channel (2022)

Figure 154: China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 155: China Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 156 : China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Ganciclovir

Figure 157 : China Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Ganciclovir

Figure 158 : China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Valganciclovir

Figure 159 : China Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Valganciclovir

Figure 160 : China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Foscarnet

Figure 161 : China Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Foscarnet

Figure 162 : China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Cidofovir

Figure 163 : China Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Cidofovir

Figure 164 : China Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Others

Figure 165 : China Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Others

Figure 166: China Cytomegalovirus Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 167: China Cytomegalovirus Treatment Market Attractiveness Analysis, By Application

Figure 168: China Cytomegalovirus Treatment Market Attractiveness Analysis, By Drug Type

Figure 169: MEA Cytomegalovirus Treatment Market Value Share, By Drug Type (2022)

Figure 170: MEA Cytomegalovirus Treatment Market Value Share, By Application (2022)

Figure 171: MEA Cytomegalovirus treatment market value analysis US$ 

Figure 172: MEA Cytomegalovirus Treatment Market Value Share, By Distribution Channel (2022) 

Figure 173: MEA Cytomegalovirus Treatment Market Value Share, By Country (2022)

Figure 174: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 175 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 176: South Africa Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 177 : South Africa Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 178 : GCC Countries Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 179 : GCC Countries Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 180 : Rest of MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021

Figure 181: Rest of MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 182 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Ganciclovir

Figure 183 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Ganciclovir

Figure 184 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Valganciclovir

Figure 185 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Valganciclovir

Figure 186 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Foscarnet

Figure 187 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Foscarnet

Figure 188 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Cidofovir

Figure 189 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Cidofovir

Figure 190 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Others

Figure 191 : MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Others

Figure 192: MEA Cytomegalovirus Treatment Market Attractiveness Analysis, By Drug Type 

Figure 193: MEA Cytomegalovirus Treatment Market Attractiveness Analysis, By Application

Figure 194: MEA Cytomegalovirus Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 195: MEA Cytomegalovirus Treatment Market Attractiveness Analysis, By Country

Figure 196: Global Cytomegalovirus Treatment Market Share Analysis (%), By Region, 2022 & 2028

Figure 197: Global Cytomegalovirus Treatment Market Y-o-Y Analysis (%), By Region, 2022-2028

Figure 198: Global Cytomegalovirus Treatment Market Attractiveness Analysis by Region, 2022-2028

Figure 199: Global Cytomegalovirus Treatment Market Share Analysis (%), By Drug Type, 2022 & 2028

Figure 200: Global Cytomegalovirus Treatment Market Y-o-Y Analysis (%), By Drug Type, 2022-2028

Figure 201: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Ganciclovir

Figure 202: MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Ganciclovir

Figure 203: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Valganciclovir

Figure 204: MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Valganciclovir

Figure 205: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Foscarnet

Figure 206: MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Foscarnet

Figure 207: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Cidofovir

Figure 208: MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Cidofovir

Figure 209: MEA Cytomegalovirus Treatment Market Value (US$ Mn) Analysis, 2013–2021, By Others

Figure 210: MEA Cytomegalovirus Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Others

Figure 211: Global Cytomegalovirus Treatment Market Attractiveness Analysis by Drug Type, 2022-2028

Figure 212: Global Cytomegalovirus Treatment Market Share Analysis (%), By Application, 2022 & 2028

Figure 213: Global Cytomegalovirus Treatment Market Y-o-Y Analysis (%), By Application, 2022-2028

Figure 214: Global Cytomegalovirus Treatment Market Attractiveness Analysis by Application, 2022-2028

Figure 215: Global Cytomegalovirus Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2028

Figure 216: Global Cytomegalovirus Treatment Market Y-o-Y Analysis (%), By Distribution Channel, 2022-2028

Figure 217: Global Cytomegalovirus Treatment Market Attractiveness Analysis by Distribution Channel, 2022-2028

Figure 218: Global Cytomegalovirus Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 219: Global Cytomegalovirus Treatment Market Size (US$ Mn) Opportunity Assessment & Y-o-Y Growth (%), 2022-2028

Figure 220: Global Cytomegalovirus Treatment Market Absolute $ Opportunity, 2022–2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Sepsis Diagnostics Market

Published : February 2022

Healthcare

Swab and Viral Transport Medium Market

Published : March 2022

Healthcare

Cytomegalovirus Treatment Market

Published : March 2022

Healthcare

Pneumonia Diagnostics Market

Published : November 2017

Google translate

Cytomegalovirus Treatment Market